First add-on perampanel for focal-onset seizures: An open-label, prospective study (vol 141, pg 132, 2020)

被引：0
|
作者：
Kim, J. H.
Kim, D. W.
Lee, S. K.
Seo, D. W.
Lee, J. W.
Park, H. J.
Lee, S. A.
机构：
来源：
ACTA NEUROLOGICA SCANDINAVICA | 2020年 / 142卷 / 04期
关键词：
D O I：
10.1111/ane.13309
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：396 / 397
页数：2
相关论文
共 50 条
  • [31] ELEVATE Study 410: Perampanel as monotherapy or first adjunctive therapy in patients with focal-onset seizures or generalised tonic-clonic seizures: Analysis by patient age
    Punia, V.
    Samad, O.
    Kumar, D.
    Ngo, L. Y.
    Malhotra, M.
    EPILEPSIA, 2022, 63 : 137 - 138
  • [32] Efficacy and safety of perampanel monotherapy in Chinese patients with focal-onset seizures: A single-center, prospective, real-world observational study
    Ma, Haiyan
    Zhu, Haitao
    Chen, Fangqing
    Yang, Yiqing
    Qu, Xuefeng
    Xu, Honghao
    Yang, Lu
    Zhang, Rui
    EPILEPSIA OPEN, 2023, 8 (04) : 1474 - 1483
  • [33] Experience of perampanel monotherapy beyond initial titration to achieve seizure freedom in patients with focal-onset seizures with newly diagnosed or currently untreated recurrent epilepsy: A post hoc analysis of the open-label Study 342 (FREEDOM)
    Husni, Ryan Edbert
    Ngo, Leock Y.
    Senokuchi, Hirofumi
    Patten, Anna
    Hiramatsu, Hidetaka
    Watanabe, Kazuaki
    Yamamoto, Takamichi
    EPILEPSIA OPEN, 2022, 7 (01) : 59 - 66
  • [34] Gabapentin as add-on therapy in children with refractory partial seizures: A 24-week, open-label extension study.
    Fichtner, K
    Appleton, R
    Murray, G
    Maton, S
    Alexander, J
    EPILEPSIA, 1999, 40 : 156 - 156
  • [35] Prospective, open-label, long-term study on levetiracetam add-on treatment in patients with refractory partial epilepsy
    Boero, G.
    Specchio, N.
    Stuppiello, M.
    Papantonio, A.
    De Agazio, G.
    De Palo, A.
    Sinisi, V.
    Santosabato, M.
    La Neve, A.
    Specchio, L. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 228 - 229
  • [36] A phase IV, prospective, post-approval study of adjunctive perampanel in Indian patients aged ≥ 12 to <18 years with focal-onset seizures: Study 508
    Ravat, Sangeeta
    Kulkarni, Rahul
    Patil, Balaji
    Dash, Amitabh
    Malhotra, Manoj
    EPILEPSIA, 2021, 62 : 271 - 271
  • [37] Prospective, open-label, long-term study on levetiracetam add-on treatment in patients with refractory partial epilepsy.
    Boero, G
    Specchio, N
    Stuppiello, M
    Papantonio, A
    De Agazio, G
    De Palo, A
    Sinisi, V
    Santosabato, M
    La Neve, A
    Specchio, LM
    EPILEPSIA, 2004, 45 : 140 - 141
  • [38] Efficacy/Safety of Low-/High-Dose Perampanel as First Adjunctive Therapy in Patients With Focal-Onset Seizures: Post Hoc Analysis of the FAME Study
    Seo, Dae Won
    Lee, JiWoong
    Dash, Amitabh
    Lee, Sang Kun
    Lee, Sang-Ahm
    Malhotra, Manoj
    EPILEPSIA, 2021, 62 : 51 - 51
  • [39] Long-term efficacy and tolerability of brivaracetam in pediatric patients with focal-onset seizures and cognitive or learning comorbidities: Post hoc analysis of an open-label trial
    Bourikas, Dimitrios
    Koch, Juliane
    de la Loge, Christine
    Dimova, Svetlana
    Elmoufti, Sami
    Moseley, Brian
    Lagae, Lieven
    EPILEPSY RESEARCH, 2025, 209
  • [40] Tocilizumab As an Add-on Therapy to Glucocorticoids during the First 3 Months of Treatment of Giant Cell Arteritis: Results of a French Multicenter Prospective Open-Label Study
    Samson, Maxime
    Devilliers, Herve
    Ly, Kim Heang
    Maurier, Francois
    Bienvenu, Boris
    Terrier, Benjamin
    Charles, Pierre
    Besancenot, Jean-Francois
    Fauchais, Anne-Laure
    Binquet, Christine
    Audia, Sylvain
    Bonnotte, Bernard
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345